ID   CASR_RAT                Reviewed;        1079 AA.
AC   P48442;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   02-OCT-2024, entry version 168.
DE   RecName: Full=Extracellular calcium-sensing receptor;
DE            Short=CaSR;
DE   AltName: Full=Parathyroid cell calcium-sensing receptor;
DE            Short=PCaR1;
DE            Short=RaKCaR {ECO:0000303|PubMed:7816802};
DE   Flags: Precursor;
GN   Name=Casr; Synonyms=Gprc2a, Pcar1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney outer medulla;
RX   PubMed=7816802; DOI=10.1073/pnas.92.1.131;
RA   Riccardi D., Park J., Lee W., Gamba G., Brown E.M., Hebert S.C.;
RT   "Cloning and functional expression of a rat kidney extracellular
RT   calcium/polyvalent cation-sensing receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:131-135(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-294.
RC   STRAIN=Wistar;
RX   PubMed=7724534; DOI=10.1073/pnas.92.8.3161;
RA   Ruat M., Snowman A.M., Snyder S.H.;
RT   "Calcium sensing receptor: molecular cloning in rat and localization to
RT   nerve terminals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:3161-3165(1995).
RN   [3]
RP   INTERACTION WITH ARRB1.
RX   PubMed=17623778; DOI=10.1242/jcs.03469;
RA   Bouschet T., Martin S., Kanamarlapudi V., Mundell S., Henley J.M.;
RT   "The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO
RT   ARF6 ELMO protein network.";
RL   J. Cell Sci. 120:2489-2497(2007).
CC   -!- FUNCTION: G-protein-coupled receptor that senses changes in the
CC       extracellular concentration of calcium ions and plays a key role in
CC       maintaining calcium homeostasis (PubMed:7816802). Senses fluctuations
CC       in the circulating calcium concentration and modulates the production
CC       of parathyroid hormone (PTH) in parathyroid glands (By similarity). The
CC       activity of this receptor is mediated by a G-protein that activates a
CC       phosphatidylinositol-calcium second messenger system (By similarity).
CC       The G-protein-coupled receptor activity is activated by a co-agonist
CC       mechanism: aromatic amino acids, such as Trp or Phe, act concertedly
CC       with divalent cations, such as calcium or magnesium, to achieve full
CC       receptor activation (By similarity). {ECO:0000250|UniProtKB:P41180,
CC       ECO:0000250|UniProtKB:Q9QY96}.
CC   -!- ACTIVITY REGULATION: In resting state, adopts an open conformation,
CC       anion-binding promoting the inactive configuration. Upon aromatic amino
CC       acid-binding, the groove in the extracellular venus flytrap module is
CC       closed, thereby inducing the formation of a novel homodimer interface
CC       between subunits. Calcium ions stabilize the active state by enhancing
CC       homodimer interactions between membrane-proximal domains to fully
CC       activate the receptor. {ECO:0000250|UniProtKB:P41180}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (By similarity). Interacts with
CC       VCP and RNF19A (By similarity). Interacts with ARRB1 (PubMed:17623778).
CC       {ECO:0000250|UniProtKB:P41180, ECO:0000269|PubMed:17623778}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P41180};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P41180}.
CC   -!- DOMAIN: The extracellular regions of the homodimer interact in a side-
CC       by-side fashion while facing opposite directions. Each extracellular
CC       region consists of three domains, LB1 (ligand-binding 1), LB2 and CR
CC       (cysteine-rich). The two lobe-shaped domains LB1 and LB2 form a venus
CC       flytrap module. In the inactive configuration, the venus flytrap
CC       modules of both protomers are in the open conformation associated with
CC       the resting state (open-open) and the interdomain cleft is empty. In
CC       addition, each protomer contains three anions, which reinforce the
CC       inactive conformation, and one calcium ion. In the active
CC       configuration, both protomers of extracellular regions have the closed
CC       conformation associated with agonist-binding (closed-closed). The
CC       ligand-binding cleft of each protomer is solely occupied by an aromatic
CC       amino-acid. Calcium is bound at four novel sites, including one at the
CC       homodimer interface. Agonist-binding induces large conformational
CC       changes within the extracellular region homodimer: first, the venus
CC       flytrap module of each protomer undergoes domain closure. Second, the
CC       LB2 regions of the two protomers approach each other, resulting in an
CC       expansion of the homodimer interactions involving LB2 domains. Third,
CC       the CR regions of the two subunits interact to form a large homodimer
CC       interface that is unique to the active state. The CR regions are
CC       brought into close contact by the motion involving LB2 since the two
CC       domains are rigidly associated within each subunit.
CC       {ECO:0000250|UniProtKB:P41180}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P41180}.
CC   -!- PTM: Ubiquitinated by RNF19A; which induces proteasomal degradation.
CC       {ECO:0000250|UniProtKB:P41180}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10354; AAC52149.1; -; mRNA.
DR   EMBL; U20289; AAC52195.1; -; mRNA.
DR   PIR; I59362; I59362.
DR   RefSeq; NP_001296567.1; NM_001309638.1.
DR   RefSeq; NP_058692.1; NM_016996.2.
DR   RefSeq; XP_017453358.1; XM_017597869.1.
DR   RefSeq; XP_017453359.1; XM_017597870.1.
DR   RefSeq; XP_017453360.1; XM_017597871.1.
DR   RefSeq; XP_017453361.1; XM_017597872.1.
DR   AlphaFoldDB; P48442; -.
DR   SMR; P48442; -.
DR   IntAct; P48442; 1.
DR   STRING; 10116.ENSRNOP00000069629; -.
DR   BindingDB; P48442; -.
DR   ChEMBL; CHEMBL2516; -.
DR   DrugCentral; P48442; -.
DR   GuidetoPHARMACOLOGY; 54; -.
DR   GlyCosmos; P48442; 10 sites, No reported glycans.
DR   GlyGen; P48442; 10 sites.
DR   iPTMnet; P48442; -.
DR   PhosphoSitePlus; P48442; -.
DR   PaxDb; 10116-ENSRNOP00000003092; -.
DR   Ensembl; ENSRNOT00000003092.6; ENSRNOP00000003092.3; ENSRNOG00000002265.8.
DR   Ensembl; ENSRNOT00055029017; ENSRNOP00055023361; ENSRNOG00055017089.
DR   Ensembl; ENSRNOT00060046779; ENSRNOP00060038904; ENSRNOG00060026973.
DR   Ensembl; ENSRNOT00065031234; ENSRNOP00065024881; ENSRNOG00065018590.
DR   GeneID; 24247; -.
DR   KEGG; rno:24247; -.
DR   UCSC; RGD:2277; rat.
DR   AGR; RGD:2277; -.
DR   CTD; 846; -.
DR   RGD; 2277; Casr.
DR   eggNOG; KOG1056; Eukaryota.
DR   GeneTree; ENSGT00940000157596; -.
DR   HOGENOM; CLU_005389_1_0_1; -.
DR   InParanoid; P48442; -.
DR   OMA; KCPDDSW; -.
DR   OrthoDB; 5308018at2759; -.
DR   PhylomeDB; P48442; -.
DR   TreeFam; TF331269; -.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-420499; Class C/3 (Metabotropic glutamate/pheromone receptors).
DR   PRO; PR:P48442; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000002265; Expressed in adult mammalian kidney and 2 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0016597; F:amino acid binding; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; ISS:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:RGD.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0032782; P:bile acid secretion; IDA:RGD.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:RGD.
DR   GO; GO:0070509; P:calcium ion import; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IEP:RGD.
DR   GO; GO:1901653; P:cellular response to peptide; IEP:RGD.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEP:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:RGD.
DR   GO; GO:0005513; P:detection of calcium ion; IDA:RGD.
DR   GO; GO:0060613; P:fat pad development; IEP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IDA:RGD.
DR   GO; GO:0007254; P:JNK cascade; IMP:RGD.
DR   GO; GO:0001503; P:ossification; IMP:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IMP:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0099505; P:regulation of presynaptic membrane potential; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0010038; P:response to metal ion; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0042311; P:vasodilation; IMP:RGD.
DR   CDD; cd15282; 7tmC_CaSR; 1.
DR   CDD; cd06364; PBP1_CaSR; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 2.10.50.30; GPCR, family 3, nine cysteines domain; 1.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR000337; GPCR_3.
DR   InterPro; IPR011500; GPCR_3_9-Cys_dom.
DR   InterPro; IPR038550; GPCR_3_9-Cys_sf.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR000068; GPCR_3_Ca_sens_rcpt-rel.
DR   InterPro; IPR017979; GPCR_3_CS.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR24061; CALCIUM-SENSING RECEPTOR-RELATED; 1.
DR   PANTHER; PTHR24061:SF358; EXTRACELLULAR CALCIUM-SENSING RECEPTOR; 1.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF07562; NCD3G; 1.
DR   PRINTS; PR00592; CASENSINGR.
DR   PRINTS; PR00248; GPCRMGR.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   PROSITE; PS00979; G_PROTEIN_RECEP_F3_1; 1.
DR   PROSITE; PS00980; G_PROTEIN_RECEP_F3_2; 1.
DR   PROSITE; PS00981; G_PROTEIN_RECEP_F3_3; 1.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Metal-binding; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1079
FT                   /note="Extracellular calcium-sensing receptor"
FT                   /id="PRO_0000012948"
FT   TOPO_DOM        20..612
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        613..635
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        636..649
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        650..670
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        671..681
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        682..700
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        701..724
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        725..745
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        746..769
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        770..792
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        793..805
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        806..828
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        829..836
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        837..862
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        863..1079
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          22..188
FT                   /note="Ligand-binding 1 (LB1)"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   REGION          189..324
FT                   /note="Ligand-binding 2 (LB2)"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   REGION          542..612
FT                   /note="Cysteine-rich (CR)"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   REGION          880..900
FT                   /note="Interaction with RNF19A"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   REGION          894..964
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        894..921
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        929..964
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         66..70
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /ligand_note="required for structural stability of the
FT                   receptor"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         81
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         84
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         87
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         88
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         100
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         145
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         147
FT                   /ligand="L-tryptophan"
FT                   /ligand_id="ChEBI:CHEBI:57912"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         168
FT                   /ligand="L-tryptophan"
FT                   /ligand_id="ChEBI:CHEBI:57912"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         170
FT                   /ligand="L-tryptophan"
FT                   /ligand_id="ChEBI:CHEBI:57912"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         231
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         234
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         297
FT                   /ligand="L-tryptophan"
FT                   /ligand_id="ChEBI:CHEBI:57912"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         415..417
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /ligand_note="required for structural stability of the
FT                   receptor"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   BINDING         557
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   MOD_RES         920
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QY96"
FT   MOD_RES         1062
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QY96"
FT   CARBOHYD        90
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        130
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        386
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        446
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        468
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        488
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        541
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        594
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        60..101
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        129
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        131
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        236..561
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        358..395
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        437..449
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        542..562
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        546..565
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        568..582
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
FT   DISULFID        585..598
FT                   /evidence="ECO:0000250|UniProtKB:P41180"
SQ   SEQUENCE   1079 AA;  120868 MW;  D7664550361F9736 CRC64;
     MASYSCCLAL LALAWHSSAY GPDQRAQKKG DIILGGLFPI HFGVAAKDQD LKSRPESVEC
     IRYNFRGFRW LQAMIFAIEE INSSPSLLPN MTLGYRIFDT CNTVSKALEA TLSFVAQNKI
     DSLNLDEFCN CSEHIPSTIA VVGATGSGVS TAVANLLGLF YIPQVSYASS SRLLSNKNQY
     KSFLRTIPND EHQATAMADI IEYFRWNWVG TIAADDDYGR PGIEKFREEA EERDICIDFS
     ELISQYSDEE EIQQVVEVIQ NSTAKVIVVF SSGPDLEPLI KEIVRRNITG RIWLASEAWA
     SSSLIAMPEY FHVVGGTIGF GLKAGQIPGF REFLQKVHPR KSVHNGFAKE FWEETFNCHL
     QEGAKGPLPV DTFVRSHEEG GNRLLNSSTA FRPLCTGDEN INSVETPYMD YEHLRISYNV
     YLAVYSIAHA LQDIYTCLPG RGLFTNGSCA DIKKVEAWQV LKHLRHLNFT NNMGEQVTFD
     ECGDLVGNYS IINWHLSPED GSIVFKEVGY YNVYAKKGER LFINEEKILW SGFSREVPFS
     NCSRDCQAGT RKGIIEGEPT CCFECVECPD GEYSGETDAS ACDKCPDDFW SNENHTSCIA
     KEIEFLAWTE PFGIALTLFA VLGIFLTAFV LGVFIKFRNT PIVKATNREL SYLLLFSLLC
     CFSSSLFFIG EPQDWTCRLR QPAFGISFVL CISCILVKTN RVLLVFEAKI PTSFHRKWWG
     LNLQFLLVFL CTFMQILICI IWLYTAPPSS YRNHELEDEI IFITCHEGSL MALGSLIGYT
     CLLAAICFFF AFKSRKLPEN FNEAKFITFS MLIFFIVWIS FIPAYASTYG KFVSAVEVIA
     ILAASFGLLA CIFFNKVYII LFKPSRNTIE EVRSSTAAHA FKVAARATLR RPNISRKRSS
     SLGGSTGSIP SSSISSKSNS EDRFPQPERQ KQQQPLSLTQ QEQQQQPLTL HPQQQQQPQQ
     PRCKQKVIFG SGTVTFSLSF DEPQKNAMAH RNSMRQNSLE AQRSNDTLGR HQALLPLQCA
     DADSEMTIQE TGLQGPMVGD HQPEMESSDE MSPALVMSTS RSFVISGGGS SVTENVLHS
//
